Skip to main content


Journal of Gastrointestinal Cancer

Journal of Gastrointestinal Cancer OnlineFirst articles

21.02.2018 | Original Research

Prognostic Factors and the Role of Adjuvant Treatment in Periampullary Carcinoma: a Single-Centre Experience of 95 Patients

Periampullary carcinomas (PAC) account for 0.5–2% of all gastrointestinal malignancies. They are defined as tumours arising within 2 cm of the major papilla in the duodenum and include four different types of malignancies, namely those originating …

19.02.2018 | Case Report Open Access

A Case of Alpha-Fetoprotein-Producing Adenocarcinoma of the Esophagogastric Junction in which Long-Term Survival Was Achieved by Means of Individualized Multidisciplinary Therapy

Carcinoma of the esophagogastric junction (EGJ) is a type of upper digestive cancer that occurs within 2 cm above or below the EGJ regardless of the histological type. Most cases of carcinoma of the EGJ are detected at an advanced stage and thus …

17.02.2018 | Original Research

Expression Level of miR-34a in Tumor Tissue from Patients with Esophageal Squamous Cell Carcinoma

Esophageal cancer is one of the most common cancers and is the sixth cause of cancer-related deaths worldwide [ 1 ]. Two common types of esophageal cancer are esophageal squamous cell carcinoma (ESCC) and adenocarcinoma that are pathologically and …

17.02.2018 | Review Article Open Access

Systemic Treatment of Patients with Advanced, Unresectable Hepatocellular Carcinoma: Emergence of Therapies

To date, sorafenib, a multiple tyrosine kinase inhibitor, is the only systemic agent approved by the FDA in the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC). Several other tyrosine kinase-inhibiting agents have …

17.02.2018 | Case Report

Inflammatory Myofibroblastic Tumor of the Mid Common Bile Duct Masquerading as Cholangiocarcinoma

Inflammatory myofibroblastic tumors (IMTs) of the biliary ducts represent an uncommon cause of obstructive jaundice. It mimics cholangiocarcinoma both clinically and radiologically. Only nine reports of the biliary IMT have been reported in the …

Aktuelle Ausgaben

Über diese Zeitschrift

The multidisciplinary Journal of Gastrointestinal Cancer publishes novel research pertaining to cancers arising from the gastrointestinal tract. Coverage spans all relevant fields, emphasizing studies that aid in understanding and treating cancers affecting the esophagus, stomach, liver, gallbladder and biliary tree, pancreas, small bowel, large bowel, rectum, and anus. The Journal also offers basic and translational scientific information from studies providing insight into the etiology and progression of cancers affecting these organs. Coverage ranges to such diverse areas of research as studies exploring pre-neoplastic states, risk factors, epidemiology, genetics, preclinical therapeutics, surgery, radiation therapy, novel medical therapeutics, clinical trials, and outcome studies. The journal also publishes case reports, state-of-the-art reviews on topics of immediate interest or importance; book reviews; Letters to the Editors; and other items of special interest.

Weitere Informationen

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.